P Galanaud

1.3k total citations
39 papers, 1.0k citations indexed

About

P Galanaud is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, P Galanaud has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in P Galanaud's work include Immune Response and Inflammation (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (6 papers). P Galanaud is often cited by papers focused on Immune Response and Inflammation (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (6 papers). P Galanaud collaborates with scholars based in France, Mali and Canada. P Galanaud's co-authors include A Vazquez, D Émilie, J F Delfraissy, Christine Wallon, Corinne Leprince, Yolande Richard, Odile Devergne, Guillaume Sébire, Marc Tardieu and Christiane Héry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

P Galanaud

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Galanaud France 21 524 204 150 136 125 39 1.0k
Dan Lehmann Israel 19 598 1.1× 169 0.8× 151 1.0× 113 0.8× 47 0.4× 36 1.2k
J F Delfraissy France 15 521 1.0× 110 0.5× 85 0.6× 115 0.8× 56 0.4× 25 912
David G. Haegert Canada 24 692 1.3× 273 1.3× 185 1.2× 82 0.6× 173 1.4× 64 1.4k
J A Carlino United States 13 1.0k 1.9× 314 1.5× 294 2.0× 95 0.7× 52 0.4× 22 1.5k
C.–C. Chan United States 13 371 0.7× 219 1.1× 87 0.6× 167 1.2× 30 0.2× 19 1.3k
Michael J. Garlepp Australia 20 521 1.0× 289 1.4× 202 1.3× 391 2.9× 48 0.4× 36 1.5k
S B Cohen United Kingdom 19 665 1.3× 162 0.8× 156 1.0× 180 1.3× 67 0.5× 42 1.4k
M Miyasaka Japan 16 580 1.1× 313 1.5× 75 0.5× 106 0.8× 32 0.3× 41 1.2k
Shigenori Harada Japan 13 377 0.7× 301 1.5× 242 1.6× 152 1.1× 88 0.7× 26 1.1k
Xiaobo Wu United States 23 853 1.6× 231 1.1× 123 0.8× 120 0.9× 52 0.4× 36 1.4k

Countries citing papers authored by P Galanaud

Since Specialization
Citations

This map shows the geographic impact of P Galanaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Galanaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Galanaud more than expected).

Fields of papers citing papers by P Galanaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Galanaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Galanaud. The network helps show where P Galanaud may publish in the future.

Co-authorship network of co-authors of P Galanaud

This figure shows the co-authorship network connecting the top 25 collaborators of P Galanaud. A scholar is included among the top collaborators of P Galanaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Galanaud. P Galanaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foussat, Arnaud, et al.. (2000). Les chimiokines et la longue marche des leucocytes.. médecine/sciences. 16(6-7). 757–757. 1 indexed citations
2.
Chérin, P., S. Herson, Marie‐Claude Crevon, et al.. (1996). Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.. PubMed. 23(7). 1135–42. 50 indexed citations
3.
Vazquez, A, et al.. (1995). B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.. The Journal of Immunology. 154(7). 3096–3104. 86 indexed citations
4.
Humbert, Marc, P Roux‐Lombard, Jacques Cerrina, et al.. (1994). Soluble TNF Receptors (TNF-sR55 and TNF-sR75) in Lung Allograft Recipients Displaying Cytomegalovirus Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 149(6). 1681–1685. 20 indexed citations
5.
Émilie, D, et al.. (1994). Interleukin 13 gene expression by normal and malignant human B lymphocytes. Cytokine. 6(5). 539–539. 1 indexed citations
6.
Sébire, Guillaume, D Émilie, Christine Wallon, et al.. (1993). In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. The Journal of Immunology. 150(4). 1517–1523. 167 indexed citations
7.
Leca, Gérald, et al.. (1991). Respiratory burst in human B lymphocytes. Triggering of surface Ig receptors induces modulation of chemiluminescence signal. The Journal of Immunology. 146(10). 3542–3549. 24 indexed citations
8.
Vazquez, A, Marie‐Thérèse Auffredou, P Galanaud, & Gérald Leca. (1991). Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP. The Journal of Immunology. 146(12). 4222–4227. 30 indexed citations
9.
Émilie, D, Christine Wallon, P Galanaud, et al.. (1988). Role of the LFA3-CD2 interaction in human specific B cell differentiation.. The Journal of Immunology. 141(6). 1912–1918. 24 indexed citations
10.
Richard, Yolande, Corinne Leprince, Bernard Dugas, Dominique Treton, & P Galanaud. (1987). Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.. The Journal of Immunology. 139(5). 1563–1567. 14 indexed citations
12.
Vazquez, A, Marie‐Thérèse Auffredou, J. -P. Gerard, J F Delfraissy, & P Galanaud. (1987). Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.. The Journal of Immunology. 139(7). 2344–2348. 7 indexed citations
13.
Dugas, Bernard, A Vazquez, J. -P. Gerard, et al.. (1985). Functional properties of two human B cell growth factor species separated by lectin affinity column.. The Journal of Immunology. 135(1). 333–338. 27 indexed citations
14.
Kopf, A, et al.. (1984). [Eosinophilic cystitis of allergic origin].. PubMed. 13(2). 83–6. 9 indexed citations
15.
Galanaud, P. (1982). Ontogénie des lymphocytes B et différenciation plasmocytaire.. 1 indexed citations
16.
Galanaud, P, et al.. (1981). Primary in vitro anti-KLH antibody formation by peripheral blood lymphocytes in man: detection with a radioimmunoassay. The Journal of Immunology. 127(6). 2621–2621. 2 indexed citations
17.
Bourée, Patrice, et al.. (1979). Outbreak of trichinosis near Paris.. BMJ. 1(6170). 1047–1049. 33 indexed citations
18.
Galanaud, P, et al.. (1977). [Primary dissecting aneurysm of the renal artery with hypertension].. PubMed. 6(12). 1037–40. 1 indexed citations
19.
Dormont, J, et al.. (1972). Leukocyte migration inhibition with spleen extracts and other antigens in patients with renal allografts.. PubMed. 4(2). 265–9. 1 indexed citations
20.
Bach, J F, et al.. (1970). [Analytic study of 69 anti-mouse lymphocyte rabbit serums. I. "In vivo" activity].. PubMed. 18(9). 471–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026